Skip to main content
Have a personal or library account? Click to login
Microscopic methods in analysis of submicron phospholipid dispersions Cover

Microscopic methods in analysis of submicron phospholipid dispersions

Open Access
|Mar 2016

References

  1. 1. P. Couvreur, Nanoparticles in drug delivery: past, present and future,.(2013) 21–23; DOI: 10.1016/j.addr.2012.04.010.
  2. 2. I. F. Uchegbu and A. Siew, Nanomedicines and nanodiagnostics come of age,.(2013) 305–310; DOI: 10.1002/jps.23377.
  3. 3. T. M. Allen and P. R. Cullis, Liposomal drug delivery systems: from concept to clinical applications,.(2013) 36–48; DOI: 10.1016/j.addr.2012.09.037.
  4. 4. E. Fattal and Ch. Vauthier,, in(Ed. J. Swarbrick), Informa Healthcare, New York 2007, pp. 1183–1200.
  5. 5. N. Anton and T. F. Vandamme, Nano-emulsions and micro-emulsions: clarification of the critical differences,.(2011) 978–985; DOI: 10.1007/s11095-010-0309-1.
  6. 6. C. R. Rowe, P. J. Sheskey and S. C. Owen,, 5ed., Pharmaceutical Press, London 2006, pp. 409–411.
  7. 7. A. Michajlik and E. Bartnikowska,, PZWL, Warsaw 1999.
  8. 8. W. Bernhard, S. Hoffmann, H. Dombrovsky, G. A. Rau, A. Kamlage, M. Kappler, J. J. Haitsma, J. Freihorst, H. von der Hardt and C. F. Poets, Phosphatidylcholine molecular species in lung surfactant: composition in relation to respiratory rate and lung development,.(2001) 725–731; DOI: 10.1165/ajrcmb.25.6.4616.
  9. 9. S. Tamilvanan, Oil-in-water emulsions: implications for parenteral and ocular delivering systems,.(2004) 489–533; DOI: 10.1016/j.plipres.2004.09.001.
  10. 10. N. A. Mazer, G. B. Benedek and M. C. Carey, Quasi elastic light-scattering studies of aqueous biliary lipid systems. Mixed micelle formation in bile salt-lecithin solutions,(1980) 601–615; DOI: 10.1021/bi00545a001.
  11. 11. W. Mehnert and K. Mäder, Solid lipid nanoparticles: production, characterization and applications,.(2012) 83–101; DOI: 10.1016/j.addr.2012.09.021.
  12. 12. S. A. Wissing, O. Kayser and R. H. Müller, Solid lipid nanoparticles for parenteral drug delivery,.(2004) 1257–1272; DOI: 10.1016/j.addr.2003.12.002.
  13. 13. M. Brandl, Vesicular phospholipid gels: a technology platform,.(2007) 15–26; DOI: 10.1080/08982100601186490.
  14. 14. M. Brandl, M. Drechsler, D. Bachmann, C. Tardi, M. Schmidtgen and K. H. Bauer, Preparation and characterization of semi-solid phospholipid dispersions and dilutions thereof,.(1998) 187–199; DOI: 10.1016/S0378-5173(98)00146-X.
  15. 15. C. Tardi, M. Drechsler, K. H. Bauer and M. Brandl, Steam sterilization of vesicular phospholipid gels,.(2001) 161–172; DOI: 10.1016/S0378-5173(01)00605-6.
  16. 16. M. Sznitowska, E. A. Dąbrowska and S. Janicki, Solubilizing potential of submicron emulsions and aqueous dispersions of lecithin,.(2002) 203–206; DOI: 10.1016/S0378-5173(02)00395-2.
  17. 17. M. Sznitowska, M. Klunder and M. Płaczek, Paclitaxel solubility in aqueous dispersions and mixed micellar solutions of lecithin,.(2008) 70–74; DOI: 10.1248/cpb.56.70.
  18. 18. M. Sznitowska, M. Bodnar, J. Petrusewicz, H. Janik and E. A. Dąbrowska, Preliminarystudies of a new lecithin-based formulation of paclitaxel,.(2009) 588–592; DOI: 10.3109/02652040802586068.
  19. 19. R. J. Haskell, Characterization of submicron systems via optical methods,.(1998) 125–129; DOI: 10.1021/js970331i.
  20. 20. V. Klang, N. B. Matsko, C. Valenta and F. Hofer, Electron microscopy of nanoemulsions: an essential tool for characterisation and stability assessment,(2012) 85–103; DOI: 10.1016/j.micron.2011.07.014.
  21. 21. J. Kuntsche, J. C. Horst and H. Bunjes, Cryogenic transmission electron microscopy (cryo-TEM) for studying the morphology of colloidal drug delivery systems,(2011) 120–137; DOI: 10.1016/j.ijpharm.2011.02.001.
  22. 22. S. Bibi, R. Kaur, M. Henriksen-Lacey, S. E. McNeil, J. Wilkhu, E. Lattmann, D. Christensen, A. R. Mohammed and Y. Perrie, Microscopy imaging of liposomes: from coverslips to environmental SEM,.(2011) 138–150; DOI: 10.1016/j.ijpharm.2010.12.021.
  23. 23. J. A. Litwin and M. Gajda,Jagiellonian University Press, Cracow 2011.
  24. 24. P. E. West,, Pacific Nanotechnology, Santa Clara 2006, pp. 1–16.
  25. 25. P. C. Schmidt,, in(Ed. J. Swarbrick), Informa Healthcare, New York 2007, pp. 3217–3256.
  26. 26. K. Akashi, H. Miyata, H. Itoh and K. Kinosita, Formation of giant liposomes promoted by divalent cations: critical role of electrostatic repulsion..(1998) 2973–2982; DOI: 10.1016/S0006-3495(98)78004-X.
  27. 27. R. M. Fernandez, K. A. Riske, L. Q. Amaral, R. Itri and M. T. Lamy, Influence of salt on the structure of DMPG studied by SAXS and optical microscopy,.(2008) 907–916; DOI: 10.1016/j.bbamem.2007.12.005.
  28. 28. C. C. Müller-Goymann, Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration,.(2004) 343–356; DOI: 10.1016/j.ejpb.2004.03.028.
  29. 29. C. C. Müller-Goymann,, in(Ed. J. Swarbrick), Informa Healthcare, New York 2007, pp. 1115–1131.
  30. 30. A. Graf, E. Ablinger, S. Peters, A. Zimmer, S. Hook and T. Rades, Microemulsions containing lecithin and sugar-based surfactants: nanoparticle templates for delivery of proteins and peptides,.(2008) 351–360; DOI: 10.1016/j.ijpharm.2007.08.053.
  31. 31. N. Rodriguez, F. Pincet and S. Cribier, Giant vesicles formed by gentle hydration and electroformation: a comparison by fluorescence microscopy,.(2005) 125–130; DOI: 10.1016/j.colsurfb.2005.01.010.
  32. 32. P. Arunothayanun, M. S. Bernard, D. Q. M. Craig, I. F. Uchegbu and A. T. Florence, The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles (niosomes) formed from a hexadecyl diglycerol ether,.(2000) 7–14; DOI: 10.1016/S0378-5173(00)00362-8.
  33. 33. S. R. Pygall, J. Whetstone, P. Timmins and C. D. Melia, Pharmaceutical applications of confocal laser scanning microscopy: the physical characterization of pharmaceutical systems,.(2007) 1434–1452; DOI: 10.1016/j.addr.2007.06.018.
  34. 34. J. Ch. Colas, W. Shi, V. S. Rao, A. Omri, M. R. Mozafari and H. Singh, Microscopical investigations of nisin-loaded nanoliposomes prepared by Mozafari method and their bacterial targeting,(2007) 841–847; DOI: 10.1016/j.micron.2007.06.013.
  35. 35. B. Ruozi, D. Belletti, A. Tombesi, G. Tosi, L. Bondioli, F. Forni and M. A. Vandelli, AFM, ESEM, TEM, and CLSM in liposomal characterization: a comparative study,(2011) 557–563; DOI: 10.2147/IJN.S14615.
  36. 36. M. A. Schubert and C. C. Müller-Goymann, Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier,.(2005) 77–86; DOI: 10.1016/j.ejpb.2005.03.006.
  37. 37. H. Zhou, Y. Yue, G. Liu, Y. Li, J. Zhang, Q. Gong, Z. Yan and M. Duan, Preparation and characterization of a lecithin nanoemulsion as a topical delivery system,.(2010) 224–230; DOI: 10.1007/s11671-009-9469-5.
  38. 38. S. A. Abraham, K. Edwards, G. Karlsson, S. MacIntosh, L. D. Mayer, C. McKenzie and M. B. Bally, Formation of transition metal-doxorubicin complexes inside liposomes,(2002) 41–54; DOI: 10.1016/S0005-2736(02)00507-2.
  39. 39. M. Ciobanu, B. Heurtault, P. Schultz, C. Ruhlmann, C. D. Muller and B. Frisch, Layersome: development and optimization of stable liposomes as drug delivery system,.(2007) 54–57; DOI: 10.1016/j.ijpharm.2007.05.037.
  40. 40. H. Teixeira, C. Dubernet, V. Rosilio, S. Benita, J. Lepault, I. Erk and P. Couvreur, New bicompartmental structures are observed when stearylamine is mixed with triglyceride emulsions,.(2000) 1329–1332; DOI: 10.1023/A:1026416208482.
  41. 41. K. Jores, W. Mehnert, M. Drechsler, H. Bunjes, C. Johann and K. Mäder, Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy,(2004) 217–227; DOI: 10.1016/j.jconrel.2003.11.012
  42. 42. A. Graf, E. Ablinger, S. Peters, A. Zimmer, S. Hook and T. Rades, Microemulsions containing lecithin and sugar-based surfactants: nanoparticle templates for delivery of proteins and peptides,.(2008) 351–360; DOI: 10.1016/j.ijpharm.2007.08.053.
  43. 43. G. De Rosa, M. De Stefano, F. Ungaro and M. I. La Rotonda, Cold field emission gun-scanning electron microscopy: a new tool for morphological and ultrastructural analysis of liposomes,.(2008) 189–192; DOI: 10.1016/j.ijpharm.2008.06.003.
  44. 44. A. Saupe, K. C. Gordon and T. Rades, Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy,.(2006) 56–62; DOI: 10.1016/j.ijpharm.2006.01.022.
  45. 45. N. G. Eskandar, S. Simovic and C. A. Prestidge, Nanoparticle coated submicron emulsions: sustainedrelease and improved dermal delivery of all--retinol,.(2009) 1764–1775; DOI: 10.1007/s11095-009-9888-0.
  46. 46. Y. Perrie, A. U. Mohammed, A. Vangala and S. E. McNeil, Environmental scanning electron microscopy offers real-time morphological analysis of liposomes and niosomes,.(2007) 27–37; DOI: 10.1080/08982100601186508.
  47. 47. A. Bogner, G. Thollet, D. Basset, P. H. Jouneau and C. Gauthier, Wet STEM: a new development in environmental SEM for imaging nano-objects included in a liquid phase,(2005) 290–301; DOI: 10.1016/j.ultramic.2005.05.005.
  48. 48. J. Sitterberg, A. Özcetin, C. Ehrhardt and U. Bakowsky, Utilising atomic force microscopy for the characterisation of nanoscale drug delivery systems,(2010) 2–13; DOI: 10.1016/j.ejpb.2009.09.005.
  49. 49. B. Ruozi, G. Tosi, E. Leo and M. A. Vandelli, Application of atomic force microscopy to characterize liposomes as drug and gene carriers,(2007) 12–22; DOI: 10.1016/j.talanta.2007.03.031.
  50. 50. X. Liang, G. Mao and K. Y. Ng, Mechanical properties and stability measurement of cholesterol-containing liposome on mica by atomic force microscopy,.(2004) 53–62; DOI: 10.1016/j.jcis.2004.05.042.
  51. 51. C. Preetz, A. Hauser, G. Hause, A. Kramer and K. Mäder, Application of atomic force microscopy and ultrasonic resonator technology on nanoscale: distinction of nanoemulsions from nanocapsules,.(2010) 141–151; DOI: 10.1016/j.ejps.2009.11.009.
  52. 52. T. Tran, T. C. Kupiec and L. A. Trissel, Quality-control analytical methods: particulate matter in injections: what is it and what are the concerns?,(2006) 202–204.
  53. 53. S. E. Langille, Particulate matter in injectable drug products,(2013) 186–200; DOI: 10.5731/pdajpst.2013.00922.
  54. 54. Ch. M. Hoo, N. Starostin, P. West and M. L. Mecartney, A comparison of atomic force microscopy (AFM) and dynamic light scattering (DLS) methods to characterize nanoparticle size distributions,(2008) 89–96; DOI: 10.1007/s11051-008-9435-7.
  55. 55. H. Kato, A. Nakamura and N. Noda, Determination of size distribution of silica nanoparticles: a comparison of scanning electron microscopy, dynamic light scattering, and flow-field-flow fractionation with multiangle light scattering methods,(2014) 144–152; DOI: 10.1166/mex.2014.1150.
  56. 56. V. Klang, C. Valenta and N. B. Matsko, Electron microscopy of pharmaceutical systems,(2013) 45–74; DOI: 10.1016/j.micron.2012.07.008.
DOI: https://doi.org/10.1515/acph-2016-0003 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 1 - 22
Accepted on: Sep 21, 2015
Published on: Mar 7, 2016
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Related subjects:

© 2016 Marcin Płaczek, Magdalena Kosela, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.